8.4 Cell Division, Cell Cycle Regulation & Cancer

Cell division is the fundamental process by which eukaryotic cells replicate their genetic material and distribute it into daughter cells. Cell cycle progression is tightly regulated by an intricate network of surveillance mechanisms (checkpoints) that monitor DNA integrity, organelle mass, and spindle attachment. Aberrations in these regulatory pathways lead to genomic instability and unbridled cellular proliferation—the hallmark of cancer.

---

Eukaryotic Cell Cycle Phases & the $G_0$ Quiescent State

The eukaryotic cell cycle is divided into two main periods: Interphase (~95% of total cycle time, during which the cell grows and copies its DNA) and M Phase (Mitosis and Cytokinesis, during which nuclear and cytoplasmic division occur).

[ G1 Phase: Cell Growth & Organelle Biogenesis ]
                      |
            (G1/S Checkpoint / R-Point)
                      |
[ S Phase: DNA Replication (2n, 2c ---> 2n, 4c) ]
                      |
[ G2 Phase: Growth & Protein Synthesis (Tubulin) ]
                      |
            (G2/M Checkpoint / MPF)
                      |
[ M Phase: Mitosis & Cytokinesis ] ---> [ 2 Daughter Cells ]

Interphase Phases

1. $G_1$ Phase (First Gap): Following cell division, the cell enters $G_1$, expanding in size and actively synthesizing mRNAs, proteins, and organellar components (mitochondria, ER). The duration of $G_1$ is the most variable phase among cell types, determining total cell cycle turnover time.
2. $S$ Phase (Synthesis): Genomic DNA is replicated with high fidelity, duplicating total chromosome mass ($2n, 2c \rightarrow 2n, 4c$). Sister chromatids remain physically paired along their length by ring-shaped protein complexes called cohesins. Centrosomes also duplicate during S phase.
3. $G_2$ Phase (Second Gap): The cell continues growing, synthesizes structural proteins necessary for mitosis (e.g., tubulin for spindle fibers), audits replicated DNA for replication errors or double-strand breaks, and prepares for entry into M phase.

$G_0$ Resting States: Quiescence, Senescence & Terminal Differentiation

Cells that pause or permanently exit the active cell cycle enter the $G_0$ state:

• Quiescent $G_0$: A reversible arrest in response to growth factor withdrawal or nutrient deprivation. Quiescent cells retain the capacity to re-enter $G_1$ upon mitogenic stimulation. Example: Naive lymphocytes or hepatocytes (which normally reside in $G_0$ but rapidly enter $G_1/S$ to regenerate liver tissue following partial hepatectomy).
• Senescent $G_0$: An irreversible arrest caused by critical telomere shortening (replicative senescence) or severe DNA damage. Senescent cells remain metabolically active but can never re-enter the cell cycle.
• Terminally Differentiated $G_0$: Permanently post-mitotic cells that have specialized and completely lost proliferative capacity under physiological conditions. Examples: Mature neurons, skeletal muscle fibers, and cardiac myocytes.

---

Cyclin-CDK Complexes & Molecular Checkpoint Surveillance

Progression through the cell cycle is propelled by heterodimeric protein complexes consisting of a catalytic subunit, a Cyclin-Dependent Kinase (CDK), and a regulatory subunit, a Cyclin. CDKs are serine/threonine kinases whose catalytic activity requires binding to a specific cyclin. While CDK protein levels remain constant throughout the cell cycle, cyclin concentrations fluctuate dramatically, synthesized and targeted for ubiquitin-mediated proteasomal degradation at specific cycle transitions.

Mitogenic Growth Factor Signaling (RTK-Ras-MAPK)
                      |
                      v
            Synthesizes Cyclin D
                      |
            Activates CDK4 / CDK6
                      |
   Partial Phosphorylation of Rb (pRb)
                      |
            Cyclin E - CDK2 Activated
                      |
   Hyperphosphorylation of Rb ---> Rb releases E2F
                                        |
                                E2F Transcribes S-Phase Genes
                                (DNA Polymerase, Thymidine Kinase)

$G_1/S$ Checkpoint (Restriction Point / R-Point)

The $G_1/S$ checkpoint is the critical point of no return. Prior to passing the R-point, a cell requires continuous extracellular mitogenic growth factors to proceed. Once past the R-point, the cell is committed to completing DNA replication and division, even if growth factors are removed.

1. Molecular Pathway of Entry:
   • Mitogenic growth factors (e.g., EGF, PDGF) binding to receptor tyrosine kinases trigger the Ras-MAPK cascade, inducing transcription of Cyclin D.
   • Cyclin D binds CDK4 and CDK6. Active Cyclin D–CDK4/6 initiates partial phosphorylation of the Retinoblastoma protein (Rb).
   • Partially phosphorylated Rb permits expression of Cyclin E, which binds CDK2. Cyclin E–CDK2 hyperphosphorylates Rb.
   • Unphosphorylated Rb normally binds and inhibits the E2F transcription factor. Upon hyperphosphorylation, Rb undergoes a conformational change and releases E2F. Free E2F transcribes genes required for S-phase entry (including DNA Polymerase $\alpha$, Thymidine Kinase, Cyclin A, and PCNA).
2. DNA Damage Response & p53 Surveillance:
   • If DNA double-strand breaks or ionizing radiation damage occurs during $G_1$, sensor kinases ATM and ATR phosphorylate and stabilize the tumor suppressor p53 ("guardian of the genome").
   • Stable p53 acts as a transcription factor, upregulating the gene encoding $p21^{\text{CIP1/WAF1}}$, a universal CDK inhibitor (CKI).
   • $p21$ binds and inactivates Cyclin D–CDK4/6 and Cyclin E–CDK2 complexes, arresting the cell in $G_1$ to allow DNA repair enzymes time to fix the damage.
   • If damage is unrepairable, p53 transactivates pro-apoptotic genes (Bax, PUMA), initiating mitochondrial intrinsic apoptosis.

$G_2/M$ Checkpoint

The $G_2/M$ checkpoint ensures that DNA replication during S phase is 100% complete and free of double-strand breaks before initiating chromosome segregation:

• Driven by Cyclin B binding to CDK1 (historically termed Maturation-Promoting Factor / M-Phase Promoting Factor, MPF).
• During $G_2$, Cyclin B–CDK1 accumulates in an inactive state due to inhibitory phosphorylation on CDK1 (Thr14/Tyr15) by Wee1 kinase.
• Upon successful completion of DNA replication, the phosphatase Cdc25 is activated, stripping the inhibitory phosphates from CDK1. Active MPF phosphorylates substrates to trigger M-phase entry:
  • Nuclear Lamins: Causes nuclear lamina breakdown.
  • Condensins: Promotes chromosome condensation.
  • Histone H1: Induces chromatin packing.
  • MAPs / Stathmin: Reorganizes microtubules to construct the mitotic spindle.

Spindle Assembly Checkpoint (SAC / M-Checkpoint)

The Spindle Assembly Checkpoint operates during Metaphase of M-phase to ensure that every single kinetochore of every chromosome is properly attached to spindle microtubules under amphitelic tension at the metaphase plate before allowing anaphase sister chromatid separation.

• Unattached Kinetochores: Generate a "wait-anaphase" signal by assembling the Mitotic Checkpoint Complex (MCC) (Mad2, BubR1, Bub3, Cdc20). MCC inhibits the multi-subunit E3 ubiquitin ligase called the Anaphase-Promoting Complex/Cyclosome (APC/C).
• Anaphase Onset: Once all kinetochores are attached under tension, MCC disassembles, activating APC/C bound to its coactivator Cdc20. APC/C polyubiquitinates Securin, targeting it for destruction by the 26S proteasome.
• Destruction of Securin releases the active protease Separase. Active Separase cleaves the Scc1/Rad21 cohesin subunit holding sister chromatids together, allowing kinetochore microtubule depolymerization to pull sister chromatids to opposite poles in Anaphase.

---

Mitosis vs. Meiosis Mechanics & Chromosomal Recombination

MITOSIS: Somatic Division (1 Division)        MEIOSIS: Germline Division (2 Divisions)
  Parent Cell (2n, 4c)                          Parent Cell (2n, 4c)
          |                                             |
    [Metaphase]                                   [Prophase I Synapsis & Crossing Over]
    Individual Chromosomes Align                  Tetrads / Homolog Pairs Align
          |                                             |
    [Anaphase]                                    [Anaphase I: Homologs Segregate]
    Sister Chromatids Separate                          |
          |                                       2 Intermediate Cells (n, 2c)
  2 Diploid Daughter Cells (2n, 2c)                     |
  (Genetically Identical)                         [Anaphase II: Sister Chromatids Separate]
                                                        |
                                                  4 Haploid Gametes (n, 1c)
                                                  (Genetically Unique)

Comparative Mechanical Overview

• Mitosis: Somatic cell division producing two genetically identical diploid ($2n, 2c$) daughter cells. Involves one round of DNA replication followed by one nuclear division.
• Meiosis: Germline cell division in gonads producing four genetically unique haploid ($n, 1c$) gametes. Involves one round of DNA replication followed by two sequential nuclear divisions (Meiosis I and Meiosis II).

Meiosis I: Reductional Division ($2n \rightarrow n$)

Meiosis I separates homologous chromosome pairs, reducing chromosome number by half:

1. Prophase I: Subdivided into five stages (Leptotene, Zygotene, Pachytene, Diplotene, Diakinesis):
   • Synapsis: During Zygotene, homologous chromosomes align precisely end-to-end, joined together by a protein zipper called the synaptonemal complex to form a tetrad (bivalent, consisting of 4 chromatids).
   • Crossing Over (Genetic Recombination): During Pachytene, the endonuclease Spo11 induces double-strand breaks. Reciprocal physical exchange of non-sister chromatid DNA segments occurs at microscopic X-shaped points called chiasmata. Crossing over breaks linkage groups, producing novel recombinant chromosomes combining maternal and paternal alleles.
2. Metaphase I & Independent Assortment: Tetrads align along the metaphase plate. According to Mendel's Law of Independent Assortment, the maternal versus paternal orientation of each homologous pair relative to the spindle poles is entirely random. The number of possible chromosome combinations in gametes due to independent assortment is: $2^n = 2^{23} \approx 8.39 \times 10^6 \text{ combinations}$
3. Anaphase I & Segregation: Homologous chromosome pairs separate and migrate to opposite poles (Mendel's Law of Segregation). Crucial Mechanism: Centromeric cohesin is protected from separase cleavage by the protein Shugoshin, keeping sister chromatids attached at centromeres.

Meiosis II: Equational Division ($n, 2c \rightarrow n, 1c$)

Meiosis II proceeds immediately without an intervening S phase. Sister chromatids align individually at Metaphase II, Shugoshin degrades, separase cleaves centromeric cohesin, and sister chromatids separate during Anaphase II, yielding four haploid gametes.

---

Non-disjunction Mechanics & Clinical Aneuploidies

Non-disjunction refers to the failure of homologous chromosomes to separate during Anaphase I, or the failure of sister chromatids to separate during Anaphase II or mitotic anaphase. Non-disjunction produces aneuploidy (abnormal chromosome number):

MEIOSIS I NON-DISJUNCTION                    MEIOSIS II NON-DISJUNCTION
Homologs fail to separate in Anaphase I     Sister chromatids fail to separate in Anaphase II
              |\                                          |
      +-------+-------+                           +-------+-------+
      |               |                           |               |
   (n + 1)         (n - 1)                     (n + 1)         (n - 1)    (n)     (n)
      |               |                           |               |        |       |
   Trisomy         Monosomy                    Trisomy         Monosomy  Normal  Normal
(100% Abnormal Gametes)                     (50% Abnormal / 50% Normal Gametes)

• Meiosis I Non-disjunction: Homologous pair moves together to one pole. Yields 100% abnormal gametes: two $(n+1)$ gametes and two $(n-1)$ gametes. Fertilization by a normal $(n)$ gamete yields two trisomic ($2n+1$) and two monosomic ($2n-1$) zygotes.
• Meiosis II Non-disjunction: Sister chromatids fail to separate. Yields 50% abnormal gametes: one $(n+1)$, one $(n-1)$, and two normal $(n)$ gametes. Fertilization yields one trisomic ($2n+1$), one monosomic ($2n-1$), and two normal ($2n$) zygotes.

MCAT Clinical Correlations: Common Human Aneuploidies

• Trisomy 21 (Down Syndrome): $47, \text{XX/XY, }+21$. Most common viable autosomal trisomy. Features: Intellectual disability, dysmorphic facial features, single palmar crease, congenital heart defects (AV septal defects), early-onset Alzheimer's disease. Over 95% of cases result from maternal Meiosis I non-disjunction, strongly correlated with advanced maternal age (due to prolonged arrest of primary oocytes in Prophase I dictyotene stage from fetal development until ovulation).
• Trisomy 18 (Edwards Syndrome): $47, +18$. Micrognathia, low-set ears, clenched fists with overlapping fingers, rocker-bottom feet, severe mortality.
• Trisomy 13 (Patau Syndrome): $47, +13$. Holoprosencephaly, microphthalmia, cleft lip/palate, polydactyly.
• Klinefelter Syndrome ($47, \text{XXY}$): Male phenotype, testicular atrophy, hypergonadotropic hypogonadism, gynecomastia, tall stature.
• Turner Syndrome ($45, \text{X}$): Female phenotype, short stature, webbed neck (cystic hygroma), streak ovaries, primary amenorrhea, coarctation of aorta.

---

Cancer Genetics: Proto-oncogenes vs. Tumor Suppressors

Cancer results from the accumulation of somatic or germline mutations in genes regulating cell proliferation, differentiation, DNA repair, and apoptosis.

Proto-oncogene (Gain-of-Function) --------> Oncogene (Dominant: 1 Hit Required)
                                            Constitutive Proliferation

Tumor Suppressor (Loss-of-Function) ------> Knudson Two-Hit Hypothesis (Recessive: 2 Hits)
                                            Loss of Cell Cycle Brake / DNA Repair

Proto-oncogenes & Oncogenes (Gain-of-Function)

• Proto-oncogenes: Normal genes that promote cell growth, signal transduction, or survival.
• Oncogenes: Mutated, overactive forms of proto-oncogenes. A mutation in just one allele (heterozygous mutation) is sufficient to drive unregulated growth; thus, oncogene mutations act in a dominant fashion.
• Mechanisms of Activation:
  1. Point Mutation: e.g., RAS GTPase. Single nucleotide substitutions at codon 12, 13, or 61 impair intrinsic GTP hydrolysis, locking Ras in a permanently active GTP-bound state, continuously stimulating the MAPK mitogenic pathway (present in 30% of cancers, especially pancreatic adenocarcinoma).
  2. Gene Amplification: e.g., HER2/neu (ERBB2) receptor tyrosine kinase amplified in 20% of breast cancers; N-MYC amplification in neuroblastoma.
  3. Chromosomal Translocation: e.g., Philadelphia Chromosome $t(9;22)(\text{q34};\text{q11})$, fusing BCR and ABL1 to generate the BCR-ABL1 constitutive tyrosine kinase in Chronic Myelogenous Leukemia (CML), sensitive to imatinib (Gleevec); Burkitt Lymphoma $t(8;14)$, placing MYC under the strong Ig heavy chain promoter.

Tumor Suppressor Genes (Loss-of-Function) & Knudson's Two-Hit Hypothesis

• Tumor Suppressor Genes (TSGs): Normal genes that inhibit cell cycle progression, promote apoptosis, or repair DNA.
• Knudson's Two-Hit Hypothesis: Inactivation of a tumor suppressor requires loss-of-function mutations in both alleles (homozygous loss); thus, TSG mutations behave in a cellular recessive fashion. In hereditary cancer syndromes, the first "hit" is an inherited germline mutation present in all cells; the second "hit" is a somatic mutation or loss of heterozygosity (LOH) acquired during life.

Key Tumor Suppressor Genes

• $p53$ (TP53): Inactivated in $>50%$ of human cancers. Loss of p53 eliminates $p21$ induction and Bax apoptosis, permitting damaged cells to divide continuously. Germline p53 mutation causes Li-Fraumeni Syndrome (sarcomas, breast cancer, brain tumors, adrenocortical carcinoma).
• $Rb$ (RB1): Inactivation frees E2F permanently, driving constitutive S-phase entry. Causes hereditary retinoblastoma and osteosarcoma.
• $APC$ (Adenomatous Polyposis Coli): Degrades $\beta$-catenin in the Wnt signaling pathway. Loss of APC allows $\beta$-catenin accumulation and nuclear translocation, turning on MYC and Cyclin D1. Causes Familial Adenomatous Polyposis (FAP) and sporadic colon cancer.
• $BRCA1 / BRCA2$: Participate in repairing DNA double-strand breaks via Homologous Recombination. Mutations lead to hereditary breast and ovarian cancer. BRCA-deficient tumors are sensitive to PARP inhibitors (synthetic lethality) by blocking single-strand break repair.

---

Cell Cycle Regulation & Cancer Gene Matrix